Bibliographic information

GuidelineSelected practice recommendations for contraceptive use, 4th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Maintained

Initiation of Progestogen-only injectable contraceptives (POIs). Postpartum (non-breastfeeding) • Less than 21 days postpartum: The first POI injection can be given. No additional contraceptive protection is needed. It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.

Recommended in favor

Strong

Notes and Remarks

The GDG considered that an injection given up to Day 7 of the menstrual cycle results in a low risk of an ovulatory cycle that could lead to pregnancy. The need for additional contraceptive protection among those switching from another hormonal method will depend on the previous method used. In the context of switching from an IUD to an injectable, there was some concern about the risk of pregnancy when removing an IUD within a cycle where there has already been intercourse. That concern led to the recommendation that the IUD be left in place until the next menstrual period. Whereas an estimated 48 hours of POP use was deemed necessary to achieve a contraceptive effect on cervical mucus, the time required for POIs to exert such an effect was uncertain. In their review of the evidence, the GDG noted that DMPA-SC efficacy is maintained when administered in the upper arm, which may be acceptable to women in addition to subcutaneous injection in the abdomen or thigh.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Selected practice recommendations for contraceptive use

Year2016
InstitutionWorld Health Organization